Argus Investors Counsel’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,828
Closed -$209K 112
2025
Q2
$209K Sell
2,828
-12
-0.4% -$835 0.15% 110
2025
Q1
$229K Sell
2,840
-31
-1% -$2.66K 0.17% 111
2024
Q4
$224K Buy
+2,871
New +$244K 0.15% 114

Other funds holding GEHC

Argus Investors Counsel's GEHC Position: Q3 2025 in Review

Argus Investors Counsel sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 2,828 shares — an estimated $209K sold.

Argus Investors Counsel first reported a position in GEHC in Q4 2024 and held it in 3 quarters. The position peaked at $229K in Q1 2025. 1,278 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Argus Investors Counsel reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Argus Investors Counsel sold 2,828 GE HealthCare shares in Q3 2025, an estimated $209K.
  • Argus Investors Counsel first reported a position in GE HealthCare in Q4 2024 and held it in 3 quarters.
  • Argus Investors Counsel's GE HealthCare position peaked at $229K in Q1 2025.
  • 1,278 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Argus Investors Counsel's 13F filing for Q3 2025, filed 28 Oct 2025.